What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) questionnaire?: Results from Eastern Cooperative Oncology Group (ECOG) study 5592

Journal of Clinical Epidemiology

Volumn 55, Issue 3, 2002, Pages 285-295

  Cella, David ^a   Eton, David T ^a   Fairclough, Diane L ^b   Bonomi, Philip ^c   Heyes, Anne E ^d   Silberman, Cheryl ^d   Wolf, Michael K ^d   Johnson, David H ^e  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d ASTRAZENECA   (United Kingdom)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Functional Assessment of Cancer Therapy Lung questionnaire; NSCLC; Trial Outcome Index

Indexed keywords

CISPLATIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ARTICLE; CANCER PATIENT; CLINICAL TRIAL; DISEASE COURSE; FUNCTIONAL ASSESSMENT; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SYMPTOM; TASK PERFORMANCE; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0036184207     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(01)00477-2     Document Type: Article

References (30)

1. Chemotherapy in advanced non-small cell lung cancer
2. The sickness impact profile: Development and final revision of a health status measure
3. The EORTC QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
4. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
5. Quality of life during clinical trials: Conceptual model for the Lung Cancer Symptom Scale (LCSS)
6. Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist
7. The memorial symptom assessment scale: An instrument for the evaluation of symptom prevalence, characteristics and distress
8. Development of a symptom distress scale
9. Food and Drug Administration requirements for approval of new anticancer drugs
10. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer
11. Improving quality of life in patients with non-small cell lung cancer: Research experience with gemcitabine
12. Quality of life (QoL) in advanced non-small cell lung cancer (NSCLC): Results from ECOG study E5592
13. Quality of life and survival: The role of multidimensional symptom assessment
14. Prognostic factors for survival in patients with inoperable lung cancer
15. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
16. Identifying meaningful intra-individual change standards for health-related quality of life measures
17. Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life
18. Measurement of health status: Ascertaining the minimal clinically important difference
19. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: Results of an Eastern Cooperative Oncology Group trial
20. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosporamide
21. Methods for the analysis of informatively censored longitudinal data
22. The measurement of observer agreement for categorical data
23. Interpreting treatment effects in randomized trials